NEW
YORK, Aug. 5, 2024 /PRNewswire/ -- The Gross Law
Firm issues the following notice to shareholders of SeaStar
Medical Holding Corporation (NASDAQ: ICU).
Shareholders who purchased shares of ICU during the class period
listed are encouraged to contact the firm regarding possible lead
plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/seastar-medical-loss-submission-form/?id=93549&from=4
CLASS PERIOD: October 31,
2022 to March 26, 2024
ALLEGATIONS: The complaint alleges that during the
class period, Defendants issued materially false and/or misleading
statements and/or failed to disclose that: (i) SeaStar and/or
Legacy SeaStar had deficient compliance controls and procedures
related to the Humanitarian Device Exemption (HDE) Application;
(ii) accordingly, there were deficiencies with the HDE Application,
the FDA was unlikely to approve the HDE Application in its present
form, and the selective cytopheretic device's regulatory prospects
were overstated; (iii) the Company had downplayed the true scope
and severity of deficiencies in its financial controls and
procedures, while overstating Defendants' efforts to remediate the
same; (iv) accordingly, SeaStar had failed to properly account for
the classification of certain outstanding warrants and the prepaid
forward agreement; (v) as a result, SeaStar was likely to restate
one or more of its previously issued financial statements; (vi)
accordingly, SeaStar's post-merger business and financial prospects
were overstated; and (vii) as a result, the Company's public
statements were materially false and misleading at all relevant
times.
DEADLINE: September 6, 2024
Shareholders should not delay in registering for this class action.
Register your information here:
https://securitiesclasslaw.com/securities/seastar-medical-loss-submission-form/?id=93549&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of ICU during the timeframe listed
above, you will be enrolled in a portfolio monitoring software to
provide you with status updates throughout the lifecycle of the
case. The deadline to seek to be a lead plaintiff is September 6, 2024. There is no cost or obligation
to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross
Law Firm is committed to ensuring that companies adhere to
responsible business practices and engage in good corporate
citizenship. The firm seeks recovery on behalf of investors who
incurred losses when false and/or misleading statements or the
omission of material information by a company lead to artificial
inflation of the company's stock. Attorney advertising. Prior
results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content to download
multimedia:https://www.prnewswire.com/news-releases/class-action-filed-against-seastar-medical-holding-corporation-icu-seeking-recovery-for-investors--contact-the-gross-law-firm-302213762.html
SOURCE The Gross Law Firm